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ABSTRACT 
Fat grafting has emerged as a very powerful tool, largely used in plastic surgery for a 
multitude of indications, including correction of contour abnormalities, breast reconstruction, 
and cosmetic procedures. However, the variability in terms of volumetric stability of the 
grafted fat and the lack of methods to measure outcomes in a reliable, easy and reproducible 
manner represent relevant limitations. To improve outcomes, the majority of the 
investigations has focused on three of the four steps of the fat grafting process, namely 
harvesting, processing, and re-injection. The preparation of the recipient site has instead 
received less attention, despite several reports suggesting an ability of determining higher fat 
survival rates, mainly through induction of cell proliferation, neo-vascularization and neo-
adipogenesis. It is therefore of utmost clinical relevance to determine whether the 
preparation of the recipient site prior to fat grafting leads to more favorable results. The aim 
of the present work is to collect and review all existing pre-clinical and clinical evidence 
regarding all methods to prepare the recipient site, to introduce a new preparation technique 
and to validate a new three-dimensional method to assess outcomes objectively.   
Four publications are included. The first manuscript provides a comprehensive 
overview of the different techniques to prepare the recipient site for fat grafting as they were 
investigated in pre-clinical studies, including external volume expansion, implantation of 
alloplastic material, administration of cell-proliferation factors, ischemia, and microneedling. 
The resulting outcomes are analyzed and the underlying mechanisms of action clarified. The 
second paper reviews all clinical studies investigating the most used preparation technique, 
external volume expansion, examining different indications, treatment protocols, outcomes, 
and complications. The third article presents an innovative and simple intraoperative external 
expansion system which applies a strong cycling negative pressure of -550 mmHg to 
enhance small-volume autologous fat grafting (40–80 mL) and discusses its background and 
its mechanism of action. In particular, this article examines our experience with recipient sites 
in the breast characterized by restrictive cicatrix or pre-irradiated tissues. Finally, the fourth 
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study validates the use of a novel, inexpensive and handheld three-dimensional scanning 
process to perform an easy and precise measurement of breast volumes and surfaces, 
extremely useful to evaluate fat grafting outcomes, especially in case of small volume 
transplantation. 
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I. INTRODUCTION 
1.1. The use of fat grafting in plastic surgery: an overview  
During the past decades, autologous fat grafting (AFG) has become a widely used and well-
established procedure in plastic surgery for both reconstructive and aesthetic purposes (Gir 
et al, 2012; Del Vecchio and Rohrich, 2012; Strong et al, 2015). Indeed, the data recently 
released by the International Society of Aesthetic Plastic Surgery show that, with more than 
1,000,000 procedures performed in 2016 over a total of 10,000,000, AFG is one of the most 
used for breast and gluteal augmentation and facial rejuvenation (ISAPS, 2016). A key 
aspect in the success of the procedure is represented by the abundance of adipose tissue in 
the body which can be removed form a donor site presenting unpleasant and excessive 
accumulation to a recipient site lacking volume (Oranges et al, 2018). Moreover, AFG is 
gaining a very relevant role in the field of regenerative medicine due to the proven 
regenerative potential displayed by the grafted fat. This effect is mainly attributed to the 
stromal vascular fraction (SVF) and already applied in the clinical setting for the treatment of 
scars, scar-related conditions, and burns (Oranges et al, 2018; Negenborn et al, 2016; 
Condé-Green et al, 2016).  
However, among its limitations a special place is occupied by a current huge 
variability in terms of graft survival (30–80%) observed by different authors who used 
different methods (Gir  et al, 2012). In order to guarantee the success of the operation and 
allow high retention rates and even large-volume transplantation, it is certainly essential to 
apply techniques that abide by the principles of AFG (Khouri RK Jr and Khouri RK, 2017). 
Therefore, the seek for evidence in AFG is motivated by the desire of establishing an 
ideal surgical strategy, which may guarantee optimal outcomes. To this end, the main focus 
has been concentrated on three of the four phases of AFG, namely fat harvesting, 
processing, and reinjection. Both pre-clinical and clinical studies have extensively analyzed 
these three phases. The evidence contained in these researches has been reviewed by 
Strong et al in 2015 (Strong et al, 2015).  
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The fourth phase of recipient site preparation, instead, has mostly been neglected 
(Gir et al, 2012; Strong et al, 2015; Oranges CM et al, 2018). Indeed, the recipient site has 
been correlated to the success of fat grafting mainly for its intrinsic characteristics, such as 
the age of the patient, mobile versus less mobile areas of the face, trauma, burns, scars, 
structural defects, and compartments on the face (Rohrich et al, 2007; Wang et al, 2017; 
Oranges et al, 2017).   
 
1.2. The preparation of the recipient site in fat grafting 
Although much less studied, the recipient site preparation has generated great interest 
especially with regard to the application of external expansion techniques. This has been 
correlated in particular to the very positive results reported for the use of the Brava system 
(Brava LLC, Miami, Fla.), a bra-like external expansion device which prepares the breast 
before AFG (Khouri and Del Vecchio, 2009). The system was described as extremely 
promising, with authors such as Del Vecchio and Bucky reporting 60%–200% increase of 
human breast volume after autologous fat injection documented by quantitative magnetic 
resonance imaging (Del Vecchio and Bucky, 2011). One of the main indications for the use 
of Brava is the need for mega-volume (>250 cc) fat grafting in and around the breast (Khouri 
RK et al, 2012), which in the opinion of the researchers could not be possible without the 
vacuum preparation of the recipient site.  
Due to its already relevant clinical use, several pre-clinical studies have been 
performed to clarify the mechanism of action of external volume expansion. Heit et al (Heit et 
al, 2012) and Lancerotto et al (Lancerotto et al, 2013) have demonstrated the induction of 
significant cell proliferation and neo-angiogenesis in the subcutaneous tissue after exposing 
mouse integument to external volume expansion, elicited even by a single two-hour external 
volume expansion cycle. 
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However, among the limitations to the use of Brava, there is the need of wearing the 
device for a minimum of 10 hours per day during the weeks before the operation, which 
requires a considerable compliance and motivation of the patient. Moreover, many conditions 
only demand limited interventions with small amount of fat grafting to correct contracted 
scars and body contouring deformities. The beneficial effect of the preparation of the 
recipient site, in particular the release of the contracture at the time of AFG has indeed 
generally been considered necessary in cases of contracted scar tissue, as seen in breasts 
with previous infection, radiation scarring, scar contracture from previous surgery, or 
congenital constriction bands, as seen in tuberous breasts (Khouri RK et al, 2014). In an 
attempt to achieve this result, many surgeons currently perform “Rigottomies,” named after 
Gino Rigotti, who described the technique, which release and stretch-expand scars by 
creating multiple tiny nicks inside the contracted tissue (Khouri RK et al, 2014). The scar is 
consequently transformed into a three-dimensional mesh, the volume of the recipient bed is 
expanded, and the interstitial fluid pressure reduced to the adequate range for graft survival 
(Khouri RK et al, 2014). 
Although external expansion is certainly the most popular, other techniques to 
prepare the recipient site prior to fat grafting exist and were investigated clinically and pre-
clinically. (Wang et al, 2017; Oranges et al, 2017; Zocchi et al, 2008). However, the available 
evidence was never reviewed. A comprehensive analysis of the literature is of extreme 
importance to objectively understand the contribution of the preparation of the recipient site 
and establish the basis to future investigations. Moreover, the need of treating in a simple 
and inexpensive way limited areas of the breast  motivates the search of innovative 
strategies. 
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1.3. Objective evaluation of fat grafting outcomes and use of three-dimensional scanning 
processes 
One of the major limitations of the research in AFG is the lack of standardized and 
reproducible methods to assess outcomes in an objective and easy manner. This applies 
particularly well to the post-operative volumetric changes able to indicate retention rate and 
stability of the grafted fat. An area where this appears to be of utmost relevance is certainly 
breast surgery, because of the large use of AFG in this context and the possibility of 
standardizing the measurement process in this anatomical region.  
However, several investigations have validated the use of three-dimensional 
photographic imaging technologies in the clinical context of autologous or prosthetic breast 
reconstruction, breast augmentation and breast reduction, with expected future applications 
also in case of AFG (Losken et al, 2005; Kovacs et al, 2006; Isogai et al, 2006; Tepper et al, 
2006; Tepper et al, 2008; Tepper et al, 2009; Choi et al, 2009). These technologies are 
overall increasingly used in plastic and reconstructive surgery, as they allow efficient pre-
operative evaluations, accurate diagnosis based on a deep understanding of the underlying 
morphology, and appropriate surgical planning based on accurate establishment of endpoint 
goals of treatment (Pfaff and Steinbacher, 2016). 
Another advantage offered by three-dimensional imaging as a powerful tool to 
objectively measure outcomes in comparison with traditional two-dimensional photography, 
is its ability of providing important additional data, such as true surface anatomy and 
volumetric and geometric parameters, including depth and surface topographic distance 
measurements (Weissler, 2017). These elements are of utmost relevance in breast surgery, 
where they can be used to evaluate symmetry, surface and volumetric changes, total breast 
volumes, volumetric distribution, and breast projection. Furthermore, breast contour, size, 
and position on the chest wall can be defied by surface and vector measurements (Tepper et 
al, 2010). 
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However, many of the devices validated for three-dimensional breast images 
capturing are of unpractical use in daily practice, due to their not portability, heaviness and 
overall expensiveness (Koban, 2018). Our group has previously described the use of a 
novel, simple and inexpensive three-dimensional scanning system for breast surface 
evaluation (Oranges, 2018). Nevertheless, our study did not validate its use in comparison to 
other clinically established three-dimensional imaging systems. 
 
1.4. Research objectives 
The present PhD thesis aims at investigating the preparation of the recipient site prior to 
AFG, its ability to improve outcomes and the complications possibly associated with its use. 
This appear to be extremely important, as the extreme variability in terms of fat graft survival 
reported in literature has already largely been explored in relation to the other phases of the 
procedure, while the preparation of the recipient site is less investigated.  
 The thesis explores overall the preparation of the recipient site with a specific focus on 
pre-expansion, presents a new method of external volume expansion and validates an 
innovative three-dimensional imaging scanning process which may be particularly useful in 
case of AFG outcomes assessment. 
 First, a comprehensive review of the pre-clinical evidence on the preparation of the 
recipient site is performed to clarify the mechanism of action of the techniques already used 
clinically and to provide an overview of the techniques whose preclinical positive outcomes 
will lead to future clinical applications. Then, a second manuscripts presents a 
comprehensive analysis of the international literature regarding all of the studies which 
investigated recipient site preparation using external expansion. These works are followed by 
a study on a novel external expansion technique to prepare the recipient site by applying a 
strong cycling negative pressure of -550 mmHg. The intra- and post-operative use of the 
procedure in case of recipient sites characterized by contracted scars or body contouring 
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deformities are reported and discussed with resulting outcomes and complications. Finally, a 
fourth manuscript validates a novel and simple three-dimensional imaging scanning process 
which allows volumes and surface distances assessment in the breast using an handled and 
inexpensive device. The implications for objective AFG outcomes assessment, especially in 
case of small volume transplantation, are examined and discussed. 
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II. PUBLICATIONS 
2.1. Manuscript 1 
The Preparation of the Recipient Site in Fat Grafting: A Comprehensive Review of the 
Preclinical Evidence.  
Journal: Plastic and Reconstructive Surgery - published 
Authors: Oranges CM, Striebel J, Tremp M, Madduri S, Kalbermatten DF, Harder Y, Schaefer DJ. 
Abstract - Background: Several methods to prepare the recipient site in fat grafting have been 
proposed in recent decades. However, to date, these procedures have never been reviewed 
exhaustively. The purpose of the present study is to provide a comprehensive overview of the 
different techniques to prepare the recipient site for fat grafting as they were investigated in 
preclinical studies, with resulting outcomes and underlying mechanisms of action. Methods: The 
PubMed/MEDLINE database was queried to search for preclinical investigations on the preparation 
of the recipient site in fat grafting using the following algorithm: ((recipient site) AND (fat grafting) 
OR (lipofilling) OR (lipograft)). A priori criteria were applied to review the resulting articles. 
Results: Thirteen animal studies met inclusion criteria. Overall, five techniques were identified: 
external volume expansion, implantation of alloplastic material (silicone sheets), administration of 
cell-proliferation factors (i.e., vascular endothelial growth factor, adipose tissue–derived stromal 
vascular fraction, and interleukin-8), ischemia, and microneedling. A positive effect on cellular 
activity (cell proliferation and angiogenesis) was demonstrated by all studies and achieved with all 
techniques. Seven of the eight authors who examined this aspect reported enhancement of fat 
graft survival. Conclusions: Improvement of fat grafting surgical outcomes is documented 
preclinically using different recipient-site preparation techniques, particularly through enhancement 
of vascularization and soft-tissue expansion. This understanding will lead to further clinical 
research, especially for those cases where improvement of the recipient site is recommended, 
such as contracted scars or preirradiated tissues. 
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Autologous fat grafting is commonly used in plastic surgery for both reconstructive and aesthetic purposes.1–3 Adipose tissue 
represents indeed a large source of tissue eas-
ily transferred from a donor site with excessive 
unpleasant accumulation to a recipient site in 
need of volume enhancement.4 Moreover, the 
grafted fat is able to express a proven regenera-
tive potential through its stromal vascular frac-
tion, already applied in the clinical setting for 
the treatment of scars, scar-related conditions, 
and burns.4–6 However, it is essential to apply 
techniques that abide by the principles of fat 
grafting to ensure high retention rates, which 
may be consistently achieved even for large- 
volume transplantation.7
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Background: Several methods to prepare the recipient site in fat grafting have 
been proposed in recent decades. However, to date, these procedures have 
never been reviewed exhaustively. The purpose of the present study is to pro-
vide a comprehensive overview of the different techniques to prepare the re-
cipient site for fat grafting as they were investigated in preclinical studies, with 
resulting outcomes and underlying mechanisms of action.
Methods: The PubMed/MEDLINE database was queried to search for preclini-
cal investigations on the preparation of the recipient site in fat grafting using 
the following algorithm: ((recipient site) AND (fat grafting) OR (lipofilling) 
OR (lipograft)). A priori criteria were applied to review the resulting articles.
Results: Thirteen animal studies met inclusion criteria. Overall, five techniques 
were identified: external volume expansion, implantation of alloplastic mate-
rial (silicone sheets), administration of cell-proliferation factors (i.e., vascular 
endothelial growth factor, adipose tissue–derived stromal vascular fraction, and 
interleukin-8), ischemia, and microneedling. A positive effect on cellular activ-
ity (cell proliferation and angiogenesis) was demonstrated by all studies and 
achieved with all techniques. Seven of the eight authors who examined this 
aspect reported enhancement of fat graft survival.
Conclusions: Improvement of fat grafting surgical outcomes is documented pre-
clinically using different recipient-site preparation techniques, particularly through 
enhancement of vascularization and soft-tissue expansion. This understanding will 
lead to further clinical research, especially for those cases where improvement of 
the recipient site is recommended, such as contracted scars or preirradiated tis-
sues. (Plast. Reconstr. Surg. 143: 1099, 2019.)
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In an effort to define an optimal surgical strat-
egy, many researchers have focused particularly 
on investigating three of the four phases of fat 
grafting (i.e., fat harvesting, processing, and rein-
jection), whereas less attention has been generally 
given to recipient-site preparation.1,3,4 The first 
three phases were analyzed extensively in preclini-
cal and clinical studies and reviewed by Strong et 
al. in 2015,3 and the preparation of the recipient 
site was recently investigated by our group in a 
comprehensive review of all clinical applications 
of external volume expansion.4
Overall, our research reviewed 1274 treated 
patients from 14 clinical studies.4 Thirteen of 
these studies used the Brava system (Brava, LLC, 
Miami, Fla.), a bra-like external volume expan-
sion device particularly useful to allow large-vol-
ume fat transplantation (>200 ml in almost the 
totality of the cases).4 With the application of a 
low negative pressure ranging from a minimum 
of −15 to a maximum of −80 mmHg for 10 to 24 
hours/day for up to 4 weeks before surgery, Brava 
was used for a multitude of indications, such as 
breast reconstruction, breast augmentation, cor-
rection of iatrogenic or congenital deformities, 
and the wish to replace preexisting implants. In 
these studies, fat graft survival ranged between 53 
and 82 percent.4 As an alternative external vol-
ume expansion procedure, intraoperative use of a 
much smaller device (Kiwi VAC-6000 with a Palm-
pump; Clinical Innovations, South Murray, Utah) 
that applies a much stronger negative pressure 
(−550 mmHg) has also been suggested, to pre-
pare recipient sites characterized by contracted 
scar and radiation therapy sequelae.8 Because of 
its already relevant clinical use, the mechanism of 
action of external volume expansion has already 
been investigated in numerous preclinical studies.
However, other techniques to prepare the 
recipient site before fat grafting exist and were 
presented in clinical or preclinical studies.9–12 The 
aim of the present work is to review the preclinical 
evidence on the preparation of the recipient site to 
clarify the mechanism of action of the techniques 
already used clinically and to provide an overview 
of the techniques whose preclinical positive out-
comes will lead to future clinical applications.
MATERIALS AND METHODS
A comprehensive review of the entire 
PubMed/MEDLINE database was performed 
between May and June of 2017 to collect the 
preclinical evidence on fat grafting recipient-site 
preparation techniques. Articles were initially 
selected by applying the following search algo-
rithm: ((fat grafting) OR (lipofilling) OR (lipo-
graft) AND (recipient site)).
We included all preclinical studies that used a 
preparation technique of the recipient site before 
fat grafting or investigated their biological effects. 
Exclusion criteria were literature reviews and 
descriptive articles with no measurable endpoint. 
There were no restrictions on time or language of 
publication. References of the publications identi-
fied initially were screened to add additional stud-
ies. Two independent assessors (C.M.O. and J.S.) 
reviewed manually all articles and extracted data 
from the publications, and a third assessor (M.T.) 
examined the articles in case of disagreement. 
All types of preparation techniques were consid-
ered, including external volume expansion, allo-
plastic material implantation, administration of 
cell-proliferating factors, ischemia, and micronee-
dling. We documented and tabulated the follow-
ing information for each article: author name(s), 
year of publication, preparation technique, ani-
mal model, comparator, and outcomes/findings.
RESULTS
The initial search returned 117 full-text 
articles, 105 of which were excluded after apply-
ing the predetermined criteria. One article was 
included after reviewing references of the publi-
cations identified initially. Therefore, 13 animal 
studies published from 1992 through 2017 were 
finally included in the analysis (Table 1).13–25
Five preparation techniques were identified: 
(1) external volume expansion, performed in six 
animal studies (122 mice, three pigs, and 20 rab-
bits)13,15–17,19,20; (2) implantation of alloplastic mate-
rial (silicone sheets), in one animal study on 25 
rabbits24; (3) administration of cell-proliferating 
factors, namely vascular endothelial growth factor 
(VEGF), adipose tissue–derived stromal vascular 
fraction, and interleukin (IL)-8, in three animal 
studies (20 mice and 24 rats)21–23; (4) ischemia, 
in one animal study (mice)14; and (5) micronee-
dling, in two animal studies on 38 rats.18,25
Outcome evaluation was performed considering 
effects on fat graft survival, vascularity, cell prolifera-
tion, skin thickness, quality of tissue, and inflamma-
tion. The preclinical outcomes and mechanism of 
actions of the five preparation techniques are exten-
sively presented below in separate paragraphs.
External Volume Expansion
With this method, an external expander is 
applied to the recipient site.4 Overall, six preclinical 
Copyright © 2019 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited. 
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studies were conducted with a wide variability in 
terms of negative pressure applied.4,26 A negative 
pressure of −25 mmHg was used in mice models 
by four authors, three of which observed stretch, 
edema, and inflammation of tissues, elements 
responsible for cell proliferation and neoangio-
genesis.4,13,16,19,20 Consequently, a proadipogenic 
effect with higher density of subdermal adipocytes 
was reported. In detail, an increase in inflam-
matory CD45+ cell density (p < 0.01) or onset of 
inflammation already apparent by the end of 
stimulation were observed by Lancerotto et al. 
and Lujan-Hernandez et al.,16,19 whereas Giatsidis 
et al. reported no difference (p > 0.05).13 Improve-
ment in cell proliferation was reported by all four 
studies, which observed an increase of the follow-
ing factors: (1) number of adipocytes, with 1.5- to 
2.2-fold increase over control following external 
volume expansion (p < 0.05)13,16,20; (2) peroxisome 
proliferator-activated receptor-γ expression, equal 
to 1.0 ± 0.17 after external volume expansion ver-
sus 0.24 ± 0.05 in the control group (p < 0.01)16; 
(3) proliferating rate of cells located in the dermis 
and epidermis, with 61 to 85 percent of Ki67-posi-
tive cells in the study group versus 36.4 percent in 
the control group (p < 0.01)15; and 1.4- to 1.9-fold 
higher proliferation rate at cell count after exter-
nal volume expansion (p < 0.05).19,20 A significant 
increase of skin and subcutaneous tissue thick-
ness was observed by two authors and reported 
as follows: 1.9-fold increase of skin thickness (p 
< 0.01),13 and 2-fold increase of the subcutane-
ous thickness (p < 0.05).20 Increased vasculariza-
tion was documented by Heit et al. and Giatsidis 
et al. and equaled, respectively, 1.5- and 1.9-fold 
increase (p = 0.01) of cutaneous or subcutaneous 
tissue blood vessel density,13,20 whereas Lancerotto 
et al. reported 49 vessels/high-magnification field 
in the study group versus 35 vessels/high-magnifi-
cation field in the control group (p < 0.01).19
A lower pressure equal to −70 mmHg was 
applied by Hsiao et al. to the dorsum of pigs for 
1 hour/day for 10 days, 1 hour/day for 20 days, 3 
hours/day for 10 days, or 3 hours/day for 20 days, 
respectively.4,15 The study demonstrated increased 
cell proliferation, vascularity, skin thickness, and 
skin loosening. The effects were stronger in the 
groups with longest exposure. Specifically, a 
higher proliferating rate of cells located in the 
dermis and epidermis was observed, with 61 to 85 
percent of Ki67-positive cells after external vol-
ume expansion versus 36.4 percent in the control 
group (p < 0.01). The increased vascularization, 
expressed as increased blood vessel density, was 
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documented with 6.2 to 9.4 blood vessels/mm2 
in the treated area versus 4.2 blood vessels/mm2 
in the control area (p < 0.001). Skin thickness 
increase, with increase of the subcutaneous thick-
ness, was documented by 63- to 90-μm epidermal 
tissue thickness in the treated area versus 49 μm 
in the control area (p < 0.05). The severity of skin 
loosening seemed to increase with longer applica-
tion of the external expansion device.
Finally, Lee et al. chose to test a much lower 
pressure (−125 mmHg), equal to the negative 
pressure used for noninvasive wound closure.4,17,27 
Treating the dorsal ear of 20 white rabbits for 1 
week before fat grafting, they obtained recipient-
site enhanced vascularization and increased fat 
graft survival.4,17,27 Specifically, they reported a 
statistically significant increase of graft survival in 
the study group versus the control group (75.4 ± 
3.9 percent versus 53.1 ± 4.3 percent, respectively; 
p < 0.001) and a statistically significant increase 
of glycerol expression, used to determine adipo-
cyte viability (183.56 ± 55.1 μg/ml/400 mg in the 
study group versus 100.32 ± 32.18 μg/ml/400 mg 
in the control group; p = 0.002).17 In this study, tis-
sue perfusion was evaluated using laser Doppler 
flowmetry and was equal to 19.98 ± 3.92 perfusion 
units in the study area versus 12.71 ± 3.23 perfu-
sion units in the control area (p = 0.02).
Another relevant aspect examined was the 
proper selection between cyclical and static pres-
sures, as cyclical use of negative pressure has 
been previously demonstrated to provide a more 
robust response.17,27,28 Although in the clinical set-
ting either cycling or continuous pressures were 
applied, all preclinical studies investigated the 
effects achieved using continuous pressure.4
The last aspects considered were the effects 
resulting from different time and durations of 
preexpansion.27 In several studies, animals were 
divided into groups with different exposure time 
ranging from one single session of 1.5 hours to 
24 hours for 28 consecutive days.4,15,17,19,20 Exter-
nal volume expansion was only applied before fat 
grafting in animal studies. No difference statisti-
cally significant was found between tissues treated 
with single 2-hour stimulation or 2 hours per day 
for 5 days.16
Administration of Cell Proliferating Factors
Three investigations conducted on mice and 
rats assessed the effects of the injection of dif-
ferent cell proliferating factors to the recipient 
site.21–23 Topcu et al. injected microspheres filled 
with VEGF before (group 1) or at the time of fat 
grafting (group 2) into the dorsal interscapular 
region of rats.21 They observed significantly better 
outcomes in terms of weight of the transplanted 
graft and vascularity in the study groups com-
pared with control. In detail, the study showed a 
statistically significant increase of graft weight that 
equalled 141.6 percent when VEGF was added at 
the time of fat transplantation and 125.3 percent 
when VEGF was added before fat transplantation, 
versus 44 percent in the control group (p < 0.05).21 
Regarding blood vessel density, they observed 7.92 
to 24.42 vessel counts per microscope area after 
administrations of VEGF microspheres versus 6.59 
in the control group (p < 0.001).21
Koh et al. co-injected matrigel containing 
bovine serum albumin, VEGF, and stromal vascu-
lar fraction into the recipient site.22 The authors 
postulated that enriching the vascular supply with 
co-implantation of stromal vascular fraction might 
improve the microenvironment and survival of the 
graft. Regarding cell proliferation, adipocyte con-
tent increased 17.8-fold when VEGF was added, 
33.6-fold with stromal vascular fraction, and 40.8-
fold with both factors combined (p < 0.05).
Finally, Shoshani et al. assessed the effect of IL-8 
on the viability of injected adipose tissue in a murine 
model.23 The study showed no significant improve-
ment in terms of fat graft weight (0.34 ± 0.20 g in 
the study group versus 0.44 ± 0.16 g in the control 
group; p = 0.23) and volumes (0.44 ± 0.23 ml ver-
sus 0.43 ± 0.25 ml in controls; p = 0.90). Also, cell 
proliferation, evaluated as induction of adipogen-
esis and measured as triglyceride concentration, did 
not improve significantly (p = 0.916).23 However, the 
authors demonstrated significantly less cyst forma-
tion in the group treated with IL-8 (p = 0.037).23
Ischemia
Gassman et al. investigated the viability of the 
grafted fat in remote ischemic preconditioned 
recipient sites of mice.14 Donors and recipients 
experienced intermittent temporary hindlimb 
tourniquet application (three cycles of 5 min-
utes’ ischemia) before harvest and transfer of fat, 
respectively. The authors were able to show an 
increase in viability and substantially less intersti-
tial fibrosis and liponecrosis in the preconditioned 
study group (p < 0.05). Fat graft viability was mea-
sured with bioluminescence and was retained at 
300 percent after ischemia versus 30 percent in 
the control group (p < 0.05).14 This was correlated 
to improved distant capillary bed tissue oxygen 
saturation and perfusion, which limited ischemic 
injury to the transferred tissue.
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Microneedling
Two preclinical studies were performed using 
microneedling in rat models with the following 
protocols: Sezgin et al. performed microneedling 
with a device called Deeproller 1.50 mm (Assos 
Pharmaceuticals, Istanbul, Turkey) equipped with 
192 microneedles of 1.5-mm length, applying 20 
back-and-forth rolling movements with standard 
pressure execution both parallel and perpendicu-
lar to the axis of the rat’s dorsum.18 Samdal et al. 
abraded the subcutaneous tissue over the right 
pectoral muscle with 20 strokes of an 18-gauge 
needle in a criss-cross pattern.25
The study by Sezgin et al. showed a higher level 
of vascularity in terms of blood vessel density, doc-
umented with 3.35 ± 2.3 capillaries/high-power 
field following microneedling versus 1.4 ± 1.19 
capillaries/high-power field in the control group 
(p < 0.01).18 The authors also noted significantly 
less inflammation (p < 0.05), cyst-vacuole forma-
tion, and fibrosis (p < 0.01) in the study group in 
comparison with the control group.18 However, 
the enhancement in adipocyte integrity and lob-
ulation, with improvement of cell proliferation 
expressed in terms of triglyceride concentration 
(438.5 ± 148.6 mg/dl in the study group versus 
351.2 ± 137.1 mg/dl in the control group), was 
found to be not statistically significant (p > 0.05).18
Samdal et al. reported reduced loss of trans-
planted fat postoperatively (fat survival index of 17 
percent in the study group versus 10 percent in the 
control group; p < 0.05) and, regarding tissue perfu-
sion, a transplanted blood flow equal to 0.187 ml/
minute/g in the study group versus 0.120 ml/
minute/g in the control group (p < 0.05).25
Alloplastic Materials
Baran et al. inserted silicone sheets in the dor-
sum of rabbits to induce capsule formation and 
thus create a recipient site with enhanced vascular-
ity.24 After 3 weeks, the sheets were removed and the 
fibrous capsule formed around the silicone sheet 
partially excised. Subsequently, two different types 
of fat tissue were transplanted: one with the lobular 
structure preserved, and the other with fat manually 
crushed and rinsed with lactated Ringer solution. In 
the area prepared with silicone sheets and injected 
with fat with preserved structure, 30 percent of fat 
tissue was recovered after 1 year. No evidence of fat 
tissue after 1 year was observed in the control areas.
DISCUSSION
The recipient site plays a key role in the suc-
cess of a fat grafting procedure.29–35 However, of 
the techniques already used clinically to prepare 
the recipient site, only the mechanism of action of 
external volume expansion was investigated pre-
clinically, whereas three clinical techniques—tun-
nelization, internal expansion, and percutaneous 
fasciotomies—were not.8–11 Instead, to the best of 
our knowledge, all other techniques identified 
by this review were studied only in the preclinical 
setting, and constitute the background for future 
clinical applications.
Overall, the studies on external volume 
expansion allow the most solid conclusions to be 
obtained. In particular, controlled noninvasive 
suction demonstrated the ability to determine cell 
strain, ischemia, and edema, which trigger inflam-
mation and lead to cell proliferation, angiogen-
esis, and adipogenesis.13,15–17,19,20 Indeed, this 
procedure is the only one that has already been 
extensively applied clinically, showing positive 
outcomes for breast reconstruction and augmen-
tation.36,37 Del Vecchio and Bucky38 summarized 
the five main reasons in favor of the clinical use 
of external volume expansion before fat grafting, 
as follows: (1) increase of overall parenchymal 
space; (2) reduced interstitial pressure for a given 
volume of graft injected; (3) breast shape modifi-
cation through augmentation of contour irregu-
larities before grafting; (4) possible omission of 
variables such as high-speed centrifugation with 
resulting shorter operating room times; and (5) 
angiogenesis, resulting from micromechanical 
forces on the recipient site. However, there are 
still limitations to the widespread adoption of this 
technique.4 These include primarily the absence 
of randomized controlled trials comparing autol-
ogous fat grafting with and without external vol-
ume expansion.4 Moreover, the need for wearing 
the device for 10 to 24 hours/day for 2 to 4 weeks 
preoperatively, according to recent published pro-
tocols, implies adequate patient compliance and 
motivation, and may be responsible for patient 
social life restriction and dropout rates.4
Promising results were shown also with the 
administration of cell proliferating factors, in 
terms of improvement of fat graft survival, vas-
cularity (blood vessel density), cell proliferation, 
and reduction of cyst formation. Topcu et al. 
administered VEGF, a glycoprotein able of induc-
ing proliferation, migration, and differentiation 
in endothelial cells, which were proven to have 
promotive effects on preadipocytes in a paracrine 
manner by means of either VEGF or some other 
soluble factors.21,39–42 Instead, the rationale for 
using IL-8 was based on its ability to accelerate 
angiogenesis and attract inflammatory cells and 
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fibroblasts, providing the injected adipocytes with 
more feeding vessels and a well-established graft 
bed to enhance their viability.43–46 Finally, Koh 
et al. showed that direct implantation of freshly 
isolated stromal vascular fraction derived from 
adipose tissue can induce a rapid and robust pro-
cess of vascular network formation through the 
dynamic reassembly of blood endothelial cells at 
the site of implantation in syngeneic mice.22
Gassman et al. studied the effects of remote 
ischemic preconditioning before fat grafting.14 
This technique has been shown to have protec-
tive effects against ischemia for several organ sys-
tems.47–49 Although the exact mechanism behind 
this technique remains unclear, several studies 
have hypothesized a complex multimodal mech-
anism.14 A previous investigation by Gassman et 
al. demonstrated that adipose tissue undergoing 
remote ischemic preconditioning before transfer 
displays several hallmarks consistent with ischemic 
tolerance, such as increased viability and reduced 
liposclerosis,50 whereas Kraemer et al. showed 
that remote ischemic preconditioning improves 
distant capillary bed tissue oxygen saturation and 
perfusion.51 Consequently, Gassman et al. sug-
gested that, in essence, this technique prepared 
the recipient site for tissue engraftment by limit-
ing the ischemic injury to the transferred tissue.
According to Sezgin et al., the mechanism of 
action of microneedling is to induce a wound-
healing process through mechanical microtrau-
matization, resulting in beneficial effects for fat 
transplantation.18,52 The technique consists of cre-
ating a multitude of microchannels that penetrate 
through the dermis, leading to the activation of 
the inflammatory cascade, similar to the normal 
wound healing process. Within this triggered 
complex cascade, fibroblast growth factor, VEGF, 
platelet-derived growth factor, and transforming 
growth factor alpha and beta are endogenously 
induced, resulting in the stimulation of fibroblasts 
and collagen production within the skin.53 Samdal 
et al. instead hypothesized that preoperative abra-
sion would increase vascularization on the recipi-
ent site and thereby increase the chance of graft 
revascularization.25,54
Finally, with alloplastic material implantation, 
the silicone sheets cause a foreign body reaction, 
and the resulting chronic inflammatory response 
delays and reduces the resorption of fat grafts. The 
outcome is explained with the longer time required 
by secondary wound healing compared with primary 
wound healing.24,55 By applying this method, Baran 
et al. were able to show that fat transplantation with 
lobular structure preserved to the well-vascularized 
areas created with alloplastic material implantation 
appeared to be a very valid option for contour defor-
mities when compared with artificial implants, even 
when the fat grafting needed to be repeated once 
per year.24 Overall, although clinical translatability 
appears possible for the procedures not yet applied 
in humans, further research on the mechanisms of 
actions and expected outcomes is required for the 
development of more standardized treatment pro-
tocols and guidelines.
CONCLUSIONS
The preclinical studies identified by this review 
and related to five techniques to prepare the recipi-
ent site in fat grafting were able to clarify the mecha-
nism of action of procedures already used clinically 
or to offer the background for future applications. 
Positive outcomes in terms of fat graft survival, vas-
cularity, cell proliferation, skin thickness, quality of 
tissue, and inflammation were differently shown 
with these techniques. However, among the differ-
ent methods, only external volume expansion has 
been extensively applied clinically, whereas other 
interventions require validation through future 
preclinical and clinical investigations.
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INTRODUCTION
During the past decades, autologous fat grafting 
(AFG) has become a well-established procedure in Plastic 
Surgery, widely used for both reconstructive and aesthetic 
purposes.1–3 According to data released by the Interna-
tional Society of Aesthetic Plastic Surgery, it is indeed 1 of 
the most common operations for breast and buttock aug-
mentation and facial rejuvenation, accounting for more 
than 1,000,000 procedures performed in 2016 over a total 
of 10,000,000.4 AFG is appreciated for providing an abun-
dant and easily available source of tissue removed from a 
donor site with excessive unpleasant accumulation to a re-
cipient site in need for volume enhancement. In addition, 
the proven regenerative potential expressed by its stromal 
vascular fraction, has been applied for the treatment of 
scars, scar-related conditions and burns.5,6
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Notably, recent research has especially focused on 3 
of the 4 phases of the procedure, namely fat harvesting, 
processing, and reinjection, while the additional step of 
recipient-site preparation has mainly been neglected.1,3 
In particular, harvesting, processing, and reinjection were 
extensively examined in a recent comprehensive review by 
Strong et al.3 published in 2015, which is the most up-to-
date available information on AFG.
Conversely, although many considerations were dedi-
cated to the recipient-site preparation and great interest 
in this regard has been generated by the external expan-
sion techniques, including the use of BRAVA system (Brava 
LLC, Miami, Fla.),7 this was never comprehensively or sys-
tematically reviewed. However, inter alia, several variables 
related to the recipient site in itself were already identified 
and correlated to AFG success (age of the patient, mobile 
versus less mobile areas of the face, trauma, burns, scars, 
structural defects, compartments on the face).8–10
The seek for evidence in fat grafting is motivated by 
the desire of establishing an ideal approach, which may 
guarantee optimal outcomes by understanding the rea-
sons underling the current huge variability in terms of 
graft survival (30–80%) observed by different authors 
who used different methods.1 The aim of the present re-
search is to present a comprehensive analysis of the in-
ternational literature regarding all of the studies, which 
investigated recipient-site preparation with a focus on ex-
ternal expansion.
MATERIALS AND METHODS
Between May and June 2017, a literature review of the 
entire PubMed/Medline database was conducted to assess 
the efficacy and complications of AFG recipient-site prep-
aration with external expansion. The search algorithm 
was: ((fat grafting) OR (lipofilling) OR (lipograft) AND 
(recipient site)).
Inclusion criteria were (1) clinical studies (case re-
ports, retrospective or prospective case series, clinical tri-
als); (2) application of a recipient-site external expansion 
technique before fat grafting. Excluded from the analy-
sis were literature reviews and descriptive articles with no 
measurable endpoint.
No restrictions on time or language of publication were 
applied. References of the publications identified initially 
were screened to add studies fulfilling inclusion criteria.
All articles were screened manually. Two investigators 
(C.M.O. and J.S.) independently reviewed and extracted 
data from the publications, which were examined by a 
third reviewer (M.T.) in case of disagreement.
All types of external expansion techniques were con-
sidered. We documented and tabulated the following 
information for each article: author name(s), year of 
publication, external expansion procedure, study design, 
number of patients, indication for treatment, comparator, 
and outcomes/findings.
RESULTS
One hundred seventeen full-text articles were ini-
tially identified, 110 of which were excluded according 
to predetermined criteria. Seven articles were included 
after reviewing references of the publications identified 
initially. Therefore, our analysis comprised 14 studies, 
which were published from 2008 through 2016. Fourteen 
clinical studies on external expansion were performed 
on 1,274 patients (4 case reports, 6 retrospective, and 
4 prospective studies). The maximum level of evidence 
was found to be equal to 3 in prospective case series. Sur-
gical indications for fat grafting were breast reconstruc-
tion after treatment for cancer, breast augmentation for 
aesthetic purposes, correction of iatrogenic deformities 
(deformity after excision of a congenital nevus as child 
and deformity due to a surgical cardiac procedure), 
correction of congenital deformities, and the wish to 
replace preexisting implants. A detailed analysis of all 
studies is reported in Table 1.
Thirteen authors used the Brava system (Brava LLC, 
Miami, Fla.), a bra-like device generating a low negative 
pressure (maximum, ˗80 mm Hg) worn for 10–24 h/d for 
2–4 weeks preoperativly.2,7,11–21 Large amount of fat trans-
plant was allowed, with 7 of the authors who performed 
megavolume fat transplant (≥ 300 cc)2,7,11,13–15,17 and almost 
the totality of cases (n = 1,272) receiving more than 200 
cc of fat graft per session in average. One to 7 sessions 
were performed to achieve satisfactory results. The studies 
reported a mean fat graft survival ranging between 53% 
and 82%.11–14 Three studies, 2 of which compared their 
outcomes with previous published series, reported signifi-
cant enhancement of fat graft survival in comparison with 
fat grafting without preexpansion.11,12,14
Brava system was used with a wide range of pressure 
values. Although some of the studies did not explic-
itly report on the pressure applied, we hypothesize that 
they used the device as initially described by Khouri et 
al.12,18–20,22,23 (˗15 to ˗25 mm Hg). Kosowski et al.21 used a 
pressure cycling between ˗ 60 and 0 mm Hg preoperatively 
and ˗20 mm Hg postoperatively, whereas Khouri et al.14 in 
2014 applied a pressure cycling between ˗80 and ˗60 mm 
Hg and “low pressure” postoperatively. Finally, Del Vec-
chio and Bucky17 stated that expansion programs were 
individualized for each patient based on lifestyle analy-
sis and psychological compliance testing, with a negative 
pressure, which in 1 of his studies was ranging from ˗1 to 
˗3 inches of mercury (˗25.4 to ˗76.2 mm Hg).15
Four studies reported the use of cyclical pressure,14,18,21,24 
whereas the remaining studies did not report on whether 
the device was used with continuous or cycling power, yet 
we believe that it was continuous as initially described.22
Regarding different time and durations of preexpan-
sion, patients started their treatment with the external 
expansion device up to 4 weeks before autologous fat 
transfer for 10–24 h/d.2,7,11,12,14–19 Postoperatively, the Brava 
system was worn for 5 days to 4 weeks, with the duration of 
application ranging from 10 to 24 h/d, only at night or for 
as many hours per day as tolerated.
The most common complications using Brava sys-
tem were localized edema (14.2%),11 temporary bruising 
and superficial skin blisters (11.3%),11,20 and fat necrosis 
(8.2%).11,12,14 The most serious complication was pneu-
mothorax, which occurred in 6 cases (0.5%), 1 of which 
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required chest tube.14,21 A complete list of complications 
observed with Brava system and AFG is reported in Table 2.
In 1 article from our group, it was used a smaller device 
called Kiwi VAC-6000M with a PalmPump (Clinical Inno-
vations, South Murray, Utah), a complete vacuum delivery 
system, which applies a stronger cycling negative pressure 
(˗550 mm Hg) for a much shorter intraoperative period 
(10 times for 30 seconds each) on localized scarred recipi-
ent sites before autologous fat injection.24 Postoperatively, 
the Kiwi VAC was applied 3 times per day for 1 minute each 
for 3 days. The authors reported a gross expansion of tis-
sue, with a macroscopic swelling that regressed slowly after 
the end of the stimulation, and a small degree of edema, 
which resolved without sequelae as complication. They 
also observed satisfactory clinical outcomes, with minimal 
morbidity and high patient acceptance and compliance.
DISCUSSION
The preparation of the recipient site was recently reported 
as extremely relevant and commonly performed by surgeons 
treating contracted scar tissues.25,26 This aspect was extensively 
examined by Khouri et al.25 in a publication appeared in 2014 
in this journal, which presented a comprehensive overview of 
fat grafting practice and techniques.26 Accordingly, the prepa-
ration of the recipient site was endorsed for the treatment of 
either contracted scar tissue or congenital constriction bands 
to allow a “cicatrix-to-matrix” transformation, with a release of 
contracture at the time of fat grafting.25,26
However, our review is the first that comprehensively 
reviewed the studies investigating the outcomes achieved 
with preexpansion performed for different indications 
and with different protocols. With our inclusion criteria, 
we identified 14 clinical articles describing the use of 2 
external expansion devices, namely Brava system and Kiwi 
VAC-6000M with a PalmPump, 13 of which reported the 
treatment of 1,274 patients with Brava system.
The mechanism of action of preexpansion was investi-
gated by 7 preclinical studies, which analyzed the impact 
of 4 variables: the value of the negative pressure applied, 
the strength of cycling versus static pressures, the duration 
and the timing of the preexpansion.
Four authors used a negative pressure of ˗25 mm Hg, 
equal to the most commonly used with Brava, in a mice mod-
el, observing tissue stretch, edema, and inflammation, factors 
which triggered cell proliferation, neoangiogenesis, and neo-
adipogenesis.24,27–30 Similarly, with a higher pressure (˗70 mm 
Hg) applied to the dorsum of pigs, Hsiao et al.31 showed an 
increase in vascularity, cell proliferation, hair follicles num-
ber, and skin thickness, yet observing simultaneous skin loos-
ening. Finally, Lee et al.32 applied a pressure of ˗ 125 mm Hg to 
the dorsal ear of 20 white rabbits for 1 week before fat grafting 
with the rationale of using the same negative pressure applied 
for noninvasive wound closure.33 They reported increased vas-
cularization of the preexpanded recipient site and, accord-
ingly, enhanced fat graft survival.32,33
Regarding the comparison between cyclical and stat-
ic pressures, Chin et al.34 demonstrated that cyclical use 
of negative pressure provides a more robust response in 
terms of epidermal proliferation and angiogenesis.32
Finally, in relation to different duration and timing 
of exposure, in animal studies this ranged from 1 single 
application of 1.5 hours to 24 hours for 28 consecutive 
days.27–33 Notably, the animal study by Lujan-Hernandez 
et al.30 showed no significant difference in terms of neo-
adipogenesis between tissues exposed to single 2 hours 
stimulation or to 2 hours daily for 5 days.33
Brava was initially described for nonsurgical breast aug-
mentation by Khouri et al.22 in 2000 to exploit the ability 
of tissues to grow when subjected to controlled distractive 
mechanical forces. The patients of this initial study were 
asked to wear a brassiere-like system with 20 mm Hg vac-
uum distraction force to each breast for 10–12 h/d over 
a 10-week period, achieving 98 ± 67% average increase of 
the breast volume at the end of the expansion treatment, 
and 55% (range, 15–115%) at 30 weeks. The authors also 
reported very high patient satisfaction, no adverse events, 
and described the device as comfortable to wear.
However, after the enthusiasm generated by this first in-
vestigations, following researches outlined the limitations of 
the procedure: only small breast-size enlargement (1 cup) 
possible, high patient compliance required, patient social 
life restriction and drop out rates around 25%, 50% of the 
volume increase only due to swelling at 10 weeks with the 
suggestion to wear the device for 16–20 weeks.12,22,35–38
Despite the consequent modest success as nonsurgical 
breast augmentation procedure, the ability of Brava to de-
termine a marked temporary increase in breast size with 
the creation of a very large fibrovascular scaffold induced 
several authors to investigate its potential as device to pre-
pare the recipient site in fat grafting procedures.12 These 
studies reduced the duration of the original protocol, with 
external volume expansion evolving from 2 to 3 months of 
static low pressure to 3 weeks individualized programs.17
Del Vecchio and Bucky17 reported 5 main reasons sup-
porting the use of Brava before fat grafting: (1) creation 
of more overall parenchymal space; (2) reduction of in-
terstitial pressure in the breast for a given volume of trans-
planted graft; (3) modification of breast shape through 
augmentation of contour irregularities before grafting; 
(4) possibility to avoid variables such as high-speed cen-
trifugation with resulting shorter operating room times; 
(5) angiogenesis, consequence of micromechanical forces 
on the recipient site.
Table 2. Complications Observed with the Use of Brava 
System and Fat Grafting
Complications No. Instances (%)
Localized edema 181 (14.2)
Temporary bruising and superficial blistering 144 (11.3)
Fat necrosis 105 (8.2)
Erythema 18 (1.4)
Ulceration necrosis 18 (1.4)
Infection 16 (1.3)
Pruritus 14 (1.1)
Dysesthesia 14 (1.1)
Microcalcification 7 (0.5)
Pneumothorax 6 (0.5)
Oil cysts 5 (0.4)
Pseudocysts 3 (0.2)
Sleeping troubles 2 (0.2)
Phlyctena 1 (0.1)
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Del Vecchio and Bucky17 also noted that the degree of 
physical expansion obtained with Brava is not merely de-
pending on the compliance of the patient, but also on the 
mechanical compliance of the recipient site. Indeed, they re-
ported that multiparous breasts expanded better than dense 
nulliparous breast, while constricted breasts expanded well 
but required additional treatments such as nipple-areola re-
ductions, percutaneous release of constriction bands to low-
er the inframammary folds, or additional grafting session to 
reshape the breasts. Moreover, Kosowski et al.21 observed that 
irradiated tissue required more sessions of fat transplantation 
in comparison to nonradiated tissue to achieve satisfactory 
results, whereas Uda et al.19 observed little skin extension in 
irradiated breast-conserving cases, resulting in poor cosmetic 
scores. Finally, regarding recipient sites characterized by con-
tracted scar tissue, Uda et al.19 reported higher improvement 
in case of total mastectomy compared with breast-conserving 
surgery, also in terms of total aesthetic score.
Recipient site features did not only impact the degree 
of expansion but also the complication rate. It was indeed 
observed a higher rate of complications in case of skin-
sparing and nipple-sparing mastectomies, explained with 
the difficult release of folds and adhesions to the chest wall 
of mastectomy skin flaps and skin excess.21 A high rate of 
skin complications was also reported in case of use of Brava 
on irradiated breast, as radiation therapy causes thinning of 
the epithelial tissue, affects blood circulation in the dermal 
tissue, and decreases dermal appendages, therefore inhibit-
ing the regenerative ability of the skin.19,39 Specifically, the 
ulceration rate was significantly larger in radiated breasts 
(6.5%) than in nonradiated breasts (1.4%) for postmastec-
tomy patients in the study by Kosowski et al.21
However, although Uda et al.19 discouraged the use of 
Brava on irradiated tissue for the above-mentioned rea-
sons, Kosowski et al.21 endorsed its use postulating that fat 
grafting to the irradiated breast could reverse radiation 
damage to yield superior results.40 Yet, also Kosowski et al.21 
outlined that radiated breast tissue is less compliant, with 
consequent overgrafting and its inherent complications 
more likely to occur, recommending a greater craftsman-
ship and experience for a safe and effective execution of 
the procedure, and performance of multiple treatments 
(> 4) with small volumes of fat grafting.21
Notably, Hammer-Hansen et al.20 emphasized the rel-
evance of the dermatological side effects of Brava. They 
urged studies documenting the extent of this problem to 
provide clinical guidance for future use of the device and 
thus minimize or completely avoid these complications 
in future patients. Our review identified and quantified 
skin side effects of Brava as follows: temporal bruising and 
superficial blistering, 11.3%; erythema, 1.4%; ulceration 
necrosis, 1.4%; pruritus, 1.1%; phlyctena, 0.1%.11,18,20,21
Pneumothorax, the most serious complication ob-
served, was reported by 2 authors who analyzed 427 and 
476 patients, respectively, and affected 6 patients (overall, 
0.5%), one of which required chest tube.14,21
Among the advantages of Brava, the authors empha-
sized that preexpanded breasts accept a greater fat trans-
plant volume per session with a higher retention rate, 
resulting in less necessary session to achieve satisfactory 
results.14,21 Indeed, we found 3 papers reporting signifi-
cant enhancement of fat graft survival compared with fat 
grafting without preexpansion,11,12,14 leading Khouri et 
al.12 to state that if Brava is not used, the patient should 
accept smaller volume of fat grafting and multiple ses-
sions, or life time implants in the aesthetic setting. We 
found a mean fat graft survival ranging between 53% and 
82%.11–14 In this regard, although we believe that the most 
meaningful outcome measure in fat grafting is percent 
augmentation instead of percent survival, as suggested by 
Khouri and Khouri41 in 2015, we here refer to percent 
survival as this was the variable reported in the studies 
included in this review. The large amount of fat trans-
plant possible after the use of Brava allowed total breast 
reconstruction and breast augmentation with satisfacto-
ry results. In fact, 7 authors performed megavolume fat 
transplant (≥ 300 cc),2,7,11,13–15,17 and almost all the patients 
(1,272 over 1,274) received an average of more than 200 
cc of fat graft per session.
Moreover, Kosowski et al.21 observed that in contrast 
to traditional methods (implants and flaps), the use of 
Brava and autologuous fat transplantation holds the 
benefit to preserve or restore sensation of the breasts. 
However, our review also observed a rate of dysesthesia 
equal to 1.1%.11
Finally, our group described the use of an alternative 
device named Kiwi VAC-6000M with a PalmPump, for 
specific indications.24 This was reported as a simple intra-
operative external expansion system, which applies the 
cycling negative pressure of ˗550 mm Hg for 5 minutes 
to enhance small-volume AFG (40–80 mL). The rationale 
of preparing the recipient site with Kiwi is to obtain the 
release of contracted scar tissues by exploiting its traction 
force, and to promote intense edema, ischemia, and in-
flammation providing an ideal environment for cell pro-
liferation and angiogenesis. The technique was described 
as especially useful in case of restrictive subdermal cica-
trix, through the creation of a vascularized scaffold that 
is seeded with fat grafts, and in case of retractions or scar-
ring as a result of radiation therapy.
CONCLUSIONS
Overall, positive outcomes were demonstrated with 
the use of external expansion in all the articles identified 
for both aesthetic and reconstructive purposes. Indeed, 
by allowing megavolume fat transplantation (> 300 cc), it 
appeared to be a valid alternative to implants for breast 
augmentation, and to free flaps and implants for breast 
reconstruction after total mastectomy. However, the low 
level of evidence of the studies that was found to be equal 
to maximum 3 in prospective case series, demonstrated 
the need of further exploring this topic.
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of improving fat graft survival. The objective of this study was to present an innovative and simple 
intraoperative external expansion system to enhance small-volume autologous fat grafting (40-80 
mL) and to discuss its background and its mechanism of action. In this system, expansion is 
performed using a complete vacuum delivery system known as the Kiwi VAC-6000M with a 
PalmPump (Clinical Innovations). The recipient site is rapidly expanded intraoperatively 10 times 
for 30 seconds each with a negative pressure of up to 550 mm Hg before autologous fat injection. 
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INTRODUCTION
Autologous fat grafting is becoming increasingly popular for soft 
tissue augmentation and reconstruction, due to improvements 
in donor site preparation and fat tissue harvesting, processing, 
and transplanting techniques. Moreover, adipose tissue demon-
strates a regenerative potential related to the presence of mesen-
chymal stem cells [1]. However, the unpredictability of volume 
enlargement and fat tissue retention continue to pose major prob-
lems. Recent studies have investigated the role of the recipient 
site and its preconditioning in order to address these concerns 
[2,3]. 
Release of the contracture at the time of fat grafting is consid-
ered necessary in cases of contracted scar tissue, as seen in breasts 
with previous infection, radiation scarring, scar contracture from 
previous surgery, or congenital constriction bands, as seen in tu-
berous breasts [4]. “Rigottomies,” named after Gino Rigotti, 
who described the technique, are commonly used to release and 
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improving fat graft survival. The objective of this study was to present an innovative and 
simple intraoperative external expansion system to enhance small-volume autologous fat 
grafting (40–80 mL) and to discuss its background and its mechanism of action. In this system, 
expansion is performed using a complete vacuum delivery system known as the Kiwi VAC-
6000M with a PalmPump (Clinical Innovations). The recipient site is rapidly expanded intra-
operatively 10 times for 30 seconds each with a negative pressure of up to 550 mm Hg before 
autologous fat injection. During this repetitive stimulation, the tissues become grossly expand-
ed, developing macroscopic swelling that regresses slowly over the course of hours following 
the cessation of the stimulus. The system sets various mechanisms in motion, including scar 
release, mechanical stimulation, edema, ischemia, and inflammation, which provide an environ-
ment conducive for cell proliferation and angiogenesis. In order to maintain the graft construct 
in its expansive state, all patients are encouraged postoperatively to use the Kiwi three times 
daily for one minute per session over the course of three days. The handling of this system is 
simple for both the patients and the surgeon. Satisfactory clinical outcomes have been achi-
eved without significant complications. 
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stretch-expand scars by creating multiple tiny nicks inside the 
contracted tissue [4]. This technique transforms the scar into a 
three-dimensional mesh, expanding the volume of the recipient 
bed, and thereby reducing the interstitial fluid pressure into the 
adequate range for graft survival [4]. Attention is paid in order 
to avoid the creation of cavities [4].
Furthermore, the efficacy of pre-expansion external vacuum 
devices has been investigated in clinical and pre-clinical studies, 
especially to allow mega-volume (250-mL range) fat grafting in 
and around the breast [5]. The Brava system, a bra-like external 
expansion device, has been successfully used by Del Vecchio 
and Bucky [6] to precondition the recipient site and obtain a 
60%–200% increase of human breast volume after autologous 
fat injection, as documented by quantitative magnetic resonance 
imaging. Moreover, Heit et al. [2] and Lancerotto et al. [3] dem-
onstrated that external volume expansion applied to mouse in-
tegument induces considerable proliferation and vascularization 
in the subcutaneous tissue, which can be elicited even by a single 
two-hour external volume expansion cycle.
IDEA
Based on the above-discussed research, we have developed a 
new method to precondition localized scarred recipient sites in-
traoperatively in a simple, time-saving, and inexpensive manner. 
In order to obtain a combination of advantages similar to those 
described for Rigottomies and for preoperative external expan-
sion systems, we apply an intraoperative external expansion de-
vice to prepare the recipient site for small-volume autologous fat 
grafts (40–80 mL) when the recipient site is characterized by a 
restrictive cicatrix or pre-irradiated tissues. 
Expansion is performed using a complete vacuum delivery 
system known as a Kiwi VAC-6000M with a PalmPump (Clini-
cal Innovations, South Murray, UT, USA). This vacuum deliv-
ery device is an integrated unit, providing an ergonomic handle 
with a simple hand-vacuum pump, thumb- or finger-activated 
vacuum release valve, and accurate vacuum indicator (Fig. 1). 
The device is relatively cheap (62 EUR) and readily available. It 
is used by gynecologists to extract fetuses. The recipient site is 
rapidly expanded intraoperatively 10 times for 30 seconds each 
with a negative pressure of up to 550 mm Hg before autologous 
fat injection (Fig. 2A, B). During this repetitive stimulation, mac-
roscopic swelling of the soft tissue is observed (Fig. 2C). The re-
Fig. 2. Intraoperative use of Kiwi on scar tissues
(A, B) The Kiwi is applied on a scarred pre-irradiated breast. (C) During the repetitive stimulation, macroscopic swelling of the soft tissue is observed.
A B C
The complete vacuum delivery system used: Kiwi VAC-6000M with 
a PalmPump (Clinical Innovations). 
Fig. 1. The external expansion device  
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cipient scaffold for fat grafts is then loosened and stretched out. 
This repetitive cycle leads to intense edema, ischemia, and in-
flammation, and provides an ideal environment for cell prolifer-
ation and angiogenesis. 
In order to maintain the graft construct in its expansive state 
and further optimize the ideal graft-to-recipient volume ratio, all 
patients are encouraged to use the Kiwi postoperatively three 
times daily for a period of one minute per session over the course 
of three days.
The procedure can be performed under local or general anes-
thesia and, in our experience, has minimal morbidity and high 
patient acceptance and compliance. Patients who undergo local 
anesthesia for the procedure tolerate the device well and report 
only some moderate discomfort and pressure during applica-
tion. The handling of the device is simple for both the patients 
and the surgeon. Postoperatively, some patients experience a 
small degree of edema, which normally resolves without sequelae.
DISCUSSION
Extreme variability is found in the literature regarding the ideal 
negative pressure to be applied on the recipient site prior to fat 
grafting. Several studies have investigated the effects of a nega-
tive pressure of -25 mm Hg applied for a single round of two 
hours or for two hours daily for five days in murine models, re-
sulting in cell proliferation, neoangiogenesis, and neoadipogen-
esis [1,2,7]. 
A lower pressure (-125 mm Hg) was applied by Lee et al. [8] 
in an experimental model involving white rabbits. This negative 
pressure was continuously applied for one week prior to fat graft-
ing. Lee et al. [8] reported improved recipient site vasculariza-
tion and, accordingly, enhanced fat graft survival. 
Finally, in their most recent clinical study of the Brava system, 
Khouri et al. [9] applied a high-vacuum cycling pump for 10 
hours per day with a negative pressure of -60 mm Hg for two to 
four weeks prior to fat grafting. 
In comparison with these reports from the recent literature, we 
apply a stronger negative pressure (-550 mm Hg) for a much 
shorter intraoperative period (five minutes). Following the rec-
ommendations of Chin et al. [10] and similarly to Khouri et al. 
[9], we apply cyclical forces to guarantee a more robust response, 
with the pump cycling between -550 mm Hg for 30 seconds to 
no pressure. 
The rationale of using Kiwi prior to fat grafting is to obtain the 
release of contracted scar tissues by exploiting its traction force, 
and to promote intense edema, ischemia, and inflammation in 
(A-C) Preoperative views of a 67-year-old woman with a complaint of contracted scar tissue on the right breast, two years after breast-conserv-
ing surgery and radiation therapy. (D-F) Postoperative views seven days after one fat grafting procedure, with 40 mL grafted after recipient site 
preconditioning with Kiwi. Release of the scar with volume restoration is visible, although slight edema may be noted in the early follow-up im-
ages.
Fig. 3. Preoperative and postoperative views
A
D
B
E
C
F
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order to provide an ideal environment for cell proliferation and 
angiogenesis. 
We hypothesize that, due to micromechanical strain, the appli-
cation of pressure to the extracellular matrix results in an incre-
ase of cell anchorage to focal adhesion sites of the extracellular 
matrix fibers, although we are not able to characterize these events 
at the molecular level. These effects have largely been shown in 
vitro, where a proliferative state is induced by acting on a gate-
control signal on global cellular activity mediated by the cyto-
skeleton [2,3]. 
The short-term use and application of high intraoperative pres-
sure in a limited area may lead to results comparable to those 
obtained through the long-term use of the device, clinically con-
firming the experimental observations of Lancerotto et al. [3]. 
Our technique may be especially useful in cases of restrictive 
subdermal cicatrix, through the creation of a vascularized scaf-
fold that is seeded with fat grafts. Conversely, it has been shown 
that the long-term use of pre-expansion has limitations, espe-
cially in severely deformed breasts after conservative surgery 
and radiation therapy, where it may induce skin complications 
such as dermatitis, pigmentation, or blistering.
In conclusion, based on our experience, we propose that this 
device is useful for preparing the recipient site for fat grafting, 
especially in cases where the surgeon must deal with retractions 
or scarring as a result of radiation therapy (Fig. 3).
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Abstract. Background/Aim: Methods to assess three-
dimensionally the breast surface are increasingly used in
plastic and reconstructive surgery. The aim of this study was
to validate the use of the Structure Sensor 3D scanner
(Occipital, Inc., Boulder, CO, USA) connected to an iPad Pro
(Apple, Inc., Cupertino, CA, USA) as a novel, inexpensive and
handheld three-dimensional scanning process. Materials and
Methods: Surface images of a medical human female anatomy
torso model of rigid plastic were repeatedly acquired with
Structure Sensor 3D scanner and compared with those
obtained using two clinically established 3D imaging systems.
Digital measurements of vector and surface breast distances
were analyzed using Mimics® Innovation Suite 20 medical
imaging software (Materialise, Leuven, Belgium). Results: The
analysis of variance (ANOVA) revealed no statistically
significant difference among measurements obtained using
different scanning processes for all the variables examined
(p>0.05). Conclusion: The study demonstrates analogous
practicability and reliability for surface image acquisition
using the newly introduced Structure Sensor 3D scanner and
other clinically established scanners. 
Three-dimensional photographic imaging technologies are
gaining an increasing role in plastic and reconstructive
surgery. They allow accurate and efficient pre-operative
analysis to formulate diagnosis and establish endpoint goals
of treatment to address the underlying morphology and, thus,
prepare an appropriate surgical plan (1).
Furthermore, in contrast to traditional two-dimensional
photography, three-dimensional imaging is growingly
regarded as a fundamental tool to objectively measure
outcomes by providing true surface anatomy (2). Notably,
volumetric and geometric parameters analyses such as depth
and surface topographic distance measurements can also be
performed, yielding important additional data (2).
These elements are considered particularly relevant in case
of breast surgery, where they can be used to evaluate
symmetry, surface and volumetric changes, including total
breast volumes, volumetric distribution, and breast
projection. Moreover, surface and vector measurements can
be assessed to define breast contour, size, and position on the
chest wall (3). 
A number of researches have indeed validated the use of
three-dimensional imaging in the clinical context of
autologous or prosthetic breast reconstruction, and breast
augmentation and reduction (3-10). Several validated devices
are available for three-dimensional breast images capturing.
However, many of them are not portable, heavyweight and
generally expensive (11). These characteristics make them of
unpractical use in the daily practice. 
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We previously described the use of a novel, simple and
inexpensive three-dimensional scanning system for breast
surface evaluation (12). The aim of this study was to validate
its use in comparison to other clinically established three-
dimensional imaging systems. 
Materials and Methods
We performed a scanning process using the Structure Sensor 3D
scanner (Occipital, Inc., Boulder, CO, USA) connected to an iPad Pro
(Apple, Inc., Cupertino, CA, USA), available at a price of 379 USD.
The device is a structured/infrared light handheld scanner that measures
11.92 (width) ×2.9 (height) ×2.8 (depth) cm and has a weight of 95 g. 
The established Vectra M5 Scanner (Canfield Scientific Inc.,
Parsippany, NJ, USA) 3D imaging system and Artec Eva 3D
scanner (Artec3D, Luxembourg, Luxembourg) were used as a
reference. The former is a stationary passive stereophotogrammetry-
based system, while the latter is a handled structured light three-
dimensional scanning system that measures 26.1 (width) ×15.8
(height) x 6.3 (depth) cm and has a weight of 850 g. The last two
devices are marketed at a higher price of over 10,000 USD. 
The tree-dimensional scans were acquired, with all systems, on
a medical human female anatomy torso model of rigid plastic
in a room with normal illumination. The torso was scanned five
times with each device. All scans were imported into the Mimics®
Innovation Suite 20 medical imaging software (Materialise, Leuven,
Belgium) to obtain from the three-dimensional images the following
clinical measurements of each breast: sternal notch-to-nipple
distance (S-N); nipple-to-inframammary fold distance (N-I); lateral
inframammary fold-to-medial inframammary fold distance (L-M);
upper pole-to-inframammary fold distance (U-I). All these distances
were calculated both as a surface measurement and as a direct
vector measurement. The vector distance between the two nipples
(N-N) was also measured.
Furthermore, a single computer tomographic (CT) scan of the torso
was also acquired and analyzed through the Mimics® Innovation
Suite 20 medical imaging software (Materialise, Leuven, Belgium) as
objective reference of the actual values of the measurements.
The analysis of variance (ANOVA) test was performed to
determine if the differences among measurements obtained using
different scanning processes were significant. Statistical significance
was defined as p<0.05. All statistical analyses were performed using
the SPSS® Advanced Statistical TM software package (ver. 13;
SPSS Inc., Chicago, IL, USA).
Results
We calculated the landmark-based vector and surface
distances. No statistically significant difference (p>0.05) was
found with regard to all mean distances measured on the
three-dimensional images captured using Structure Sensor
3D scanner, Vectra M5 scanner or Artec Eva 3D scanner.
Moreover, no statistically significant difference was found in
comparison to the images obtained using the CT scanner
(p>0.05), with the only exception of the N-I surface distance
of the left breast. 
In detail, the following results were observed with regard to
vector distances: mean L-M distance was equal in the right and
left breast for each scanner with the exception of the CT scan,
and ranged between 129.56 mm (SD=0.40) measured with
Vectra M5 scanner and 130.07 mm (SD=1.34) measured with
Artec Eva 3D scanner, with no statistical difference (p=0.77 in
the right breast and p=0.75 in the left breast); mean S-N
distance ranged between 179.07 mm (SD=1.06) and 179.77 mm
(SD=0.78) in the right breast (p=0.43) and between 175.97 mm
(SD=0.85) and 176.41 mm (SD=1.22) in the left breast
(p=0.67); mean N-I distance ranged between 69.18 mm
(SD=0.51) and 69.79 mm (SD=0.41) in the right breast
(p=0.35) and between 69.45 mm (SD=0.38) and 70.03 mm
(SD=0.83) in the left breast (p=0.42); mean U-I distance ranged
between 167.64 mm (SD=0.68) and 168.11 mm (SD=0.24) in
the right breast (p=0.34) and between 166.07 mm (SD=0.12) in
the left breast (p=0.20). Finally, the mean N-N vector distance
ranged between 195.94 mm (SD=0.44) and 196.57 mm
(SD=1.88), with no statistically significant difference (p=0.72).
The detailed results regarding surface distances analysis are
the following: mean L-M distance ranged between 187.81 mm
(SD=1.25) and 189.30 mm (SD=0.99) in the right breast
(p=0.1) and between 185.44 mm (SD=0.49) and 185.58
(SD=0.61) in the left breast (p=0.8); mean S-N distance
ranged between 179.99 mm (SD=0.45) and 180.80 mm
(SD=0.77) in the right breast (p=0.1) and between 178.96 mm
(SD=0.81) and 179.26 mm (SD=0.99) in the left breast
(p=0.09); mean U-I distance ranged between 196.87 mm
(SD=0.35) and 197.15 mm (SD=0.30) in the right breast
(p=0.45) and between 195.40 mm (SD=0.32) in the left breast
(p=0.70). Finally, the mean surface N-I distance ranged
between 69.43 mm (SD=0.31) and 69.73 mm (SD=0.44) in
the right breast (p=0.40) and between 69.39 mm (SD=0.29)
and 69.64 mm (SD=0.19) in the left breast (p=0.39), with no
statistically significant difference among the Structure Sensor
3D scanner, Vectra M5 scanner or Artec Eva 3D scanner.
However, in this last group, a statistically significant
difference was observed with the CT scan images (p=0.0004).
Discussion
The application of three-dimensional imaging to breast
surgery is a fast-developing concept that has been validated
to date by a number of studies for both accuracy and
reproducibility of the technology (1-9, 13-18). This has been
considered particularly useful for the pre-operative planning
and post-operative assessment of operations such as breast
reconstruction, breast augmentation and breast reduction, as
well as for the assessment of fat grafting outcomes where
also small volume variations must be considered (3, 19-21).
Our aim was to validate the use of an innovative and
inexpensive scanning process.
In their comprehensive overview of the topic, Tepper et al.
introduced the concept of mammometrics, defined as the
establishment of fixed planes and points on three-dimensional
in vivo 33: 839-842 (2019)
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images to perform objective breast measurements (3). We
calculated vectors and surface distances among landmarks of
the breast and bony anatomical landmarks of the torso that
represent important clinical measurements. The difference
among the distances obtained using Structure Sensor and the
established Vectra M5 scanner and Artec Eva 3D scanner, that
was not found to be statistically significant, allowed us to
validate the new scanning process. 
The reasons for comparing Structure Sensor with Vectra M5
scanner and Artec Eva 3D scanner are based on the already
validated use of these devices. In particular, Vectra technology
has been used to capture face, neck, breast and body (13)
while the clinical use of Artec Eva 3D has been described for
the surface assessment of face, torso, upper and lower
extremity (22-29). All three scanning processes showed
consistent results also in comparison with the CT scanning,
with only one exception, further demonstrating their accuracy. 
A previous research compared the use of Structure Sensor
and VECTRA®XT (Canfield Scientific, NJ, USA) 3D
camera system, reaching the similar conclusion that
Structure Sensor offers sufficient three-dimensional imaging
quality to measure breast distances and volumes (11). In
comparison with this research, which was performed in
female breast patients, we decided to perform our
measurements by using a medical human female anatomy
torso model of rigid plastic in order to reduce the possible
biases related to the need of ensuring the correct positioning
of the patients or artifacts from highly moveable areas.
Moreover, our results were also confronted with those
obtained with Artec Eva 3D and CT scanners, ensuring a
high level of objectivity. 
The advantages of the use of Structure Sensor are
certainly the portability, easy handleability and the low cost.
However, both Vectra M5 and Artec Eva 3D solutions offer
advanced software applications which are able to support the
analysis of the three-dimensional images. For this purpose,
the alternative use of an open access software such as
MeshLab 2016 is possible but more complex and requires
higher levels of training.
Overall, these findings are particularly important for their
applications in the continuously evolving research in the
field of breast and body contouring surgeries for both
reconstructive and aesthetic purposes (30-36). 
In conclusion, this research was able to validate the use of
Structure Sensor 3D scanner (Occipital, Inc., Boulder, CO,
USA) for breast surface assessment. However, further research
in this area is needed to develop standardized procedures that
can be used in the daily plastic and reconstructive surgery
practice.
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III. DISCUSSION 
The objective of the present PhD thesis was to explore the preparation of the recipient site as 
a way of improving outcomes of AFG and to develop methods to assess results. In a first 
paper, we analyzed all existing literature on the studies which investigated different methods 
to prepare the recipient site prior to AFG in a pre-clinical setting, examining their mechanism 
of action and measurable endpoints. In a second manuscript, we analyzed all clinical studies 
on the preparation of the recipient site through pre-expansion, with resulting outcomes and 
possible complications. In a third article, we presented a novel external expansion method to 
prepare the recipient site using a device generating high cycling negative pressure, and 
discussed related indications, treatment protocol, and observed results. Finally, in a fourth 
paper we validated a novel, inexpensive and handled scanning process to evaluate breast 
volume and surface distances, with the aim of allowing objective measurements, particularly 
useful in case of AFG. 
Overall, these four studies analyzed the best available evidence on the research in 
the field of the preparation of the recipient site in AFG and established innovative preparation 
and outcome assessment methods. 
 
3.1  Pre-clinical and clinical evidence on the preparation of the recipient site in fat grafting 
The success of the fat grafting procedure is substantially correlated to the characteristics and 
potential preparation of the recipient site (Rohrich and Pessa, 2007; Khouri RK et al, 2014; 
Del Vecchio and Del Vecchio, 2014; Khouri RK et al, 2014; Khouri RK Jr et al, 2014; Wang et 
al, 2017; Oranges et al, 2017). The first two publications included in this thesis provide a 
comprehensive analysis of methods used to prepare the recipient site based on both the pre-
clinical and clinical evidence, with a special focus on external expansion. 
Our review of the pre-clinical studies, revealed that a total number of 13 animal 
studies which applied five preparation techniques were published between 1992 and 2017. 
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We identified the following techniques: 1. external volume expansion; 2. implantation of 
alloplastic material (silicone sheets); 3. administration of cell-proliferating factors, namely 
vascular endothelial growth factor (VEGF), adipose tissue–derived stromal vascular fraction, 
and interleukin (IL)-8; 4. ischemia; 5. microneedling. In detail, external volume expansion was 
investigated in six animal studies on 122 mice, three pigs, and 20 rabbits (Giatsidis et al, 
2017; Hsiao et al, 2016; Lujan-Hernandez et al, 2016; Lee et al, 2015; Lancerotto et al, 2013; 
Heit et al, 2012); implantation of alloplastic material in one animal study on 25 rabbits (Baran 
et al, 2002); administration of cell-proliferating factors in three animal studies (20 mice and 
24 rats) (Topcu et al 2012; Koh et al, 2011; Shoshani et al, 2005); ischemia in one animal 
study (mice) (Gassman, Lewis and Lee, 2016); and microneedling in two animal studies on 
38 rats. (Sezgin et al, 2014; Samdal et al, 1992). 
The best evidence was found to be provided by the studies on controlled non-invasive 
suction, whose mechanism of action was therefore clarified. In particular, its application was 
able to determine a significant level of cell strain, ischemia, and edema (Giatsidis et al, 2017; 
Hsiao et al, 2016; Lujan-Hernandez et al, 2016; Lee et al, 2015; Lancerotto et al, 2013; Heit 
et al, 2012). These factors were correlated to the success of AFG due to their ability of 
triggering inflammation and lead to cell proliferation, angiogenesis, and adipogenesis. The 
impact of four pre-expansion variables was examined: the value of the negative pressure 
applied, the strength of cycling versus static pressures, the duration and the timing of the 
pre-expansion. There was no significant difference observed among these variables with the 
exception of the cyclical use of negative pressure which yielded a more robust response (Lee 
et al, 2015, Chin et al, 2010).  
A positive effect on AFG was also shown with the use of alloplastic material 
implantation, namely delayed and reduced resorption of fat grafts. In this case, the 
mechanism of action was correlated to the foreign body reaction caused by the silicone 
sheets with a resulting chronic inflammatory response. The outcomes were therefore 
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explained with the longer time required by secondary wound healing compared with primary 
wound healing (Baran et al, 2002; Nguyen et al, 1990). 
Improvement of fat graft survival was also obtained with the administration of cell 
proliferating factors, and associated to increased vascularity (blood vessel density) and cell 
proliferation. A further positive outcome was the reduction of cyst formation. 
Remote ischemic preconditioning prior to AFG showed an increase in viability and 
substantially less interstitial fibrosis and liponecrosis in the pre-conditioned study group 
(Gassman et al, 2016). Gassman et al explained their findings with the improvement of 
distant capillary bed tissue oxygen saturation and perfusion, which limited ischemic injury to 
the transferred tissue.  
Finally, regarding microneedling, a beneficial effect for fat transplantation was 
achieved through a higher level of vascularity expressed by higher blood vessel density, 
significantly less inflammation, cyst-vacuole formation, and fibrosis, according to the study by 
Sezgin et al (Sezgin et al, 2014). Overall, the mechanism of action of microneedling was 
therefore to induce a wound healing process through mechanical microtraumatization 
(Sezgin et al, 2014; Aust et al, 2011). 
In summary, our review of the pre-clinical studies on the preparation of the recipient 
site in AFG clarified  the mechanism of action of five techniques, explaining the outcomes of 
procedures already used clinically or offering the background for future clinical applications. 
Although achieved to different extents, all techniques showed positive outcomes in terms of 
fat graft survival, vascularity, cell proliferation, skin thickness, quality of tissue, and 
inflammation. However, with the exception of external volume expansion, whose use has 
already been widely applied in the clinical setting, the other techniques still require validation 
through future pre-clinical investigations and translation to clinics. 
After the comprehensive analysis of the mechanisms of action, the second 
manuscript  focused on reviewing all evidence provided by the clinical studies on the 
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preparation of the recipient site through external expansion. For the first time, all studies 
reporting outcomes and complications observed with pre-expansion performed for different 
indications and with different protocols were exhaustively examined.  
Our inclusion criteria allowed the identification and final inclusion of 14 clinical papers, 
published from 2008 through 2016, describing the use of two external expansion devices, 
namely Brava system (Brava LLC, Miami, Fla.) and Kiwi VAC-6000M with a PalmPump 
(Clinical Innovations). With regard to the study design, we found 4 case reports, 6 
retrospective, and 4 prospective studies. The maximum level of evidence was equal to 3 in 
prospective case series. Thirteen  studies reported the treatment of 1,274 patients with the 
Brava system, while the single study that used Kiwi was published by our group and is 
discussed below in detail as part of this dissertation. 
Brava was used in cases where the surgical indications for fat grafting were: breast 
reconstruction after mastectomy, aesthetic breast augmentation, correction of iatrogenic 
deformities emerging after excision of a congenital nevus or surgical cardiac procedure, 
correction of congenital deformities, and the desire of replacing pre-existing implants. The 
use of external expansion showed positive outcomes in all of the articles identified for both 
aesthetic and reconstructive purposes. In particular, one of the advantages was the ability of  
allowing megavolume fat transplantation (>250 cc), establishing AFG as valid alternative to 
implants for breast augmentation, and to free flaps and implants for breast reconstruction 
after total mastectomy. However, the use of the device was limited by the required significant 
degree of patient compliance and motivation, as Brava needed to be worn for 10 to 24 
hours/day for 2 to 4 weeks pre-operatively according to recent published protocols, with a 
potential impact to patient social life and dropout rates. 
Overall, the studies identified by our review confirmed the beneficial impact of using 
the Brava system before AFG, summarized by Del Vecchio and Bucky in 5 main points 
referred to the breast (Del Vecchio and Bucky, 2011): (1) increase of parenchymal space; (2) 
reduction of interstitial pressure for a given volume of fat graft; (3) modification of breast 
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shape to correct contour irregularities before grafting; (4) shorter operating room times by 
avoiding variables such as high-speed centrifugation; (5) induction of neo-angiogenesis as a 
consequence of the application of micromechanical forces. 
However, despite the relatively large number of patients involved and the very 
promising results, the low level of evidence of the clinical studies implied the necessity of 
further researching the topic, possibly with randomized controlled trials comparing AFG with 
and without external volume expansion.  
 
3.2. The use of high cycling negative pressure in the preparation of fat grafting recipient site  
On the basis of the previous research discussed above, we developed and applied an 
innovative external expansion method to prepare the recipient site in case of localized 
restrictive cicatrix or pre-irradiated tissues. The new procedure was intended to be 
significantly simpler, time-saving and less expensive in comparison with the Brava system, 
although designed for different indications. This was the subject of our third manuscript. 
The procedure used a complete vacuum delivery system called Kiwi VAC-6000M with 
a PalmPump (Clinical Innovations, South Murray, UT, USA). The external expansion was 
performed  intraoperatively by generating a negative pressure of up to -550 mmHg before 
small-volume AFG (40–80 mL). The recipient site was rapidly expanded 10 times for 30 
seconds each. This repetitive cycle generated macroscopic swelling of the soft tissue, 
loosened and stretched out the recipient scaffold, and leaded to intense edema, ischemia, 
and inflammation. An ideal environment for cell proliferation and angiogenesis was therefore 
observed. The use of Kiwi was also recommended during the first three post-operative days 
three times daily for a period of one minute per session, to maintain the graft construct in an 
expansive state and further optimize the ideal graft-to-recipient volume ratio in this very 
critical moment for graft intake.  
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Due to its use for localized conditions, the procedure could be performed under local 
anesthesia, while it was performed under general anesthesia if indicated by the overall 
patient conditions and surgical indications. The morbidity was minimal, with some patients 
presenting small degree of post-operative edema, normally resolving without sequelae. 
Conversely, the long-term use of Brava was associated to skin complications such as 
dermatitis, pigmentation, or blistering, particularly in severely deformed breasts after 
conservative surgery and radiation therapy (Uda et al, 2014). 
Moreover, we observed high patient acceptance and compliance, which represented 
a further advantage in comparison with Brava, by definition offered to highly motivated 
patients willing to wear the device for several hours per day during the pre-operative weeks.  
The handling of Kiwi was also reported as simple for both patients and surgeon. The patients 
who underwent local anesthesia for the procedure tolerated the device well reporting only 
some moderate discomfort and pressure during application. Our clinical observations 
supported the idea that short-term use and application of high intraoperative pressure in a 
limited area can produce outcomes comparable to those obtained by using in the long-term 
devices generating low pressures, confirming previous experimental findings by Lancerotto 
et al (Lancerotto et al, 2013). In order to obtain an even stronger effect in a short time we 
also applied cyclical forces, as indicated by the research of Chin et al (Chin et al, 2010) and 
similarly to Khouri et al (Khouri, 2015), with the pump cycling between  -550 mmHg for 30 
seconds to no pressure. 
However, although the use of Kiwi appeared very promising and with limited risk, 
further research will be required to further explore, validate and quantify the positive impact 
of using the procedure. 
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3.3 Validation of a novel three-dimensional method to assess breast volumes and surface 
distances 
Assessment of AFG outcomes where also small volume variations must be considered 
require the use of sophisticated technologic devices. This is also generally required for 
objective pre-operative planning and post-operative assessment of operations such as breast 
reconstruction, breast augmentation and breast reduction (Tepper et al, 2010; Oranges et al, 
2018; Oranges et al, 2016; Oranges and Schaefer, 2016). To this end, the use of three-
dimensional imaging in breast surgery is rising and has now been validated for both accuracy 
and reproducibility of the technology by several studies (Losken et al, 2005; Kovacs et al, 
2006; Isogai et al, 2006; Tepper et al, 2006; Tepper et al, 2008; Tepper et al, 2009; Tepper 
et al, 2010; Donfrancesco et al, 2013; Tzou et al, 2014; Chang et al, 2015; Epstein et al, 
2015; Pfaff et al, 2016; Chae et al, 2016; Weissler et al, 2017; de Runz et al, 2018). The aim 
of our fourth manuscript was to validate the use of an innovative scanning process.  
Our new system used the Structure Sensor 3D scanner (Occipital, Inc., Boulder, CO, 
USA) connected to an iPad Pro (Apple, Inc., Cupertino, Calif.). We compared  its use with 
the already clinically established Vectra M5 (Canfield Scientific Inc., Parsippany, NJ, USA) 
and Artec Eva 3D (Artec3D, Luxembourg, Luxembourg) scanners. The Vectra technology 
has been used to capture face, neck, breast and body (Tzou et al, 2014), whereas Artec Eva 
3D scanning system for surface assessment of face, torso, upper and lower extremities 
(Modabber et al, 2016; Yamamoto et al, 2016; Modabber et al, 2016; Seminati et al, 2017; 
Koban et al, 2018; Verhulst et al, 2018; Grant et al, 2019). 
On the basis of previous research by Tepper et al which first described the concept of 
mammometrics, defined as the establishment of fixed planes and points on three-
dimensional images to perform objective breast measurements (Tepper et al, 2010), we 
calculated and compared vectors and surface distances among anatomical landmarks of the 
breast and bony anatomical landmarks of the torso. The absence of statistically significant 
difference among these relevant clinical measurements obtained using the different methods 
50 
 
allowed the validation of the new scanning process. Moreover, the accuracy of the three 
scanning processes was also confirmed by the consistency of the data with those obtained 
using a Computed Tomography (CT) scanning process as gold standard. 
Our results were congruous with previous research which also compared Structure 
Sensor 3D scanner and VECTRA®XT 3D camera system, reporting that Structure Sensor 
offered sufficient three-dimensional imaging quality to measure breast distances and 
volumes (Koban et al, 2018). However, we believe that our investigation was superior as the 
measurements were performed on a medical human female anatomy torso model of rigid 
plastic instead of female breast patients. This allowed to minimize biases related to the 
possibility of incorrect positioning of the patients or artifacts from highly moveable areas. 
Additionally, the high level of objectivity was also ensured by the further comparison with 
Artec Eva 3D and CT scanners. 
The advantages of using Structure Sensor were certainly its portability, easy 
handleability and low cost. Indeed, it is available for 379 USD, can be easily connected to an 
iPad Pro, and has a weight of only 95 g. Instead, both Vectra M5 and Artec Eva 3D have a 
cost of over 10’000 USD, and are, respectively, the former a stationary passive 
stereophotogrammetry-based system and the latter a handled structured light three-
dimensional device with a weight of 850 g.  
Our findings support the use of this innovative tool, whose wide availability could 
overall facilitate the daily plastic surgery practice and the continuously evolving research in 
the field of breast and body contouring surgeries for both reconstructive and aesthetic 
purposes. It would be also particularly beneficial for objective AFG outcomes evaluation 
(Gabka et al, 1998; Munhoz et al, 2014; Amabile et al, 2015; Oranges et al, 2016; Gigli et al, 
2017; Tremp et al, 2017; di Summa et al, 2019). 
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3.4. Conclusion 
The preparation of the recipient site prior to fat grafting is a key aspect for the success of the 
procedure, mainly performed through pre-expansion. Based on the present work we propose 
the use of a novel pre-expansion device to be used in case of contracted scars or limited 
body contouring deformities. A novel three-dimensional scanning process has also been 
validated to measure breast volume and surface distances, allowing objective outcome 
evaluation for future investigations on fat grafting.  
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